# myNEO

> Computational target discovery and therapeutic design.

## Why it is interesting

Arcturus plans to integrate myNEO's computational platform into mRNA design and target identification, extending a collaboration that began in 2024.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** other
- **Status:** private
- **Industries:** N/A
- **Coverage:** stub
- **Last updated:** 2026-09-25

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 25, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/myneo